• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.

作者信息

Palmer A M, Wilcock G K, Esiri M M, Francis P T, Bowen D M

出版信息

Brain Res. 1987 Jan 20;401(2):231-8. doi: 10.1016/0006-8993(87)91408-9.

DOI:10.1016/0006-8993(87)91408-9
PMID:2434191
Abstract

Seven markers of ascending (corticopetal) dopaminergic, noradrenergic and serotonergic neurones and choline acetyltransferase activity have been studied postmortem in frontal and temporal cortex from subjects with Alzheimer's disease and compared with a matched group of controls. Dopaminergic neurones (concentrations of dopamine, dihydroxyphenylacetic acid and homovanillic acid) were not deficient but some markers of the other neurones were affected. Noradrenaline and serotonin concentrations were reduced whereas the concentrations of their metabolites were either unaltered (5-hydroxyindoleacetic acid) or increased (3-methoxy-4-hydroxyphenylglycol). All deficits were most pronounced in the temporal cortex. Severely demented subjects had evidence of generalized neuronal loss, whereas those with moderate dementia showed significant loss of only choline acetyltransferase activity. In Alzheimer subjects, a significant relationship (inverse) was found between 5-hydroxyindoleacetic acid concentration and the number of neurofibrillary tangles.

摘要

相似文献

1
Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
Brain Res. 1987 Jan 20;401(2):231-8. doi: 10.1016/0006-8993(87)91408-9.
2
Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.在阿尔茨海默病中生前评估的儿茶酚胺能神经元。
Brain Res. 1987 Jun 30;414(2):365-75. doi: 10.1016/0006-8993(87)90018-7.
3
Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis.阿尔茨海默病:基底核中单胺和螺哌隆结合减少。
Ann Neurol. 1986 Jun;19(6):602-4. doi: 10.1002/ana.410190616.
4
Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.阿尔茨海默病脑区中的单胺类神经递质及其代谢产物:一项尸检研究
Cell Mol Neurobiol. 1992 Dec;12(6):581-7. doi: 10.1007/BF00711237.
5
Regional changes in monoamines and metabolites following defensive aggression in the rat.大鼠防御性攻击后单胺类物质及其代谢产物的区域变化
Brain Res Bull. 1984 Mar;12(3):227-32. doi: 10.1016/0361-9230(84)90050-9.
6
Seasonal and circadian monoamine variations in human brains examined post mortem.死后检测人类大脑中的季节性和昼夜单胺变化。
Acta Psychiatr Scand Suppl. 1980;280:75-85.
7
Reverse-phase high-performance liquid chromatographic separation and electrochemical detection of norepinephrine, dopamine, serotonin, and related major metabolites.去甲肾上腺素、多巴胺、5-羟色胺及相关主要代谢产物的反相高效液相色谱分离与电化学检测
Anal Biochem. 1981 Apr;112(2):223-31. doi: 10.1016/0003-2697(81)90285-2.
8
Biogenic amines distribution in the brain of nervous and normal pointer dogs. A genetic animal model of anxiety.生物胺在神经型和正常指示犬大脑中的分布。一种焦虑症的遗传动物模型。
Neuropsychopharmacology. 1990 Aug;3(4):297-303.
9
Postmortem changes in catecholamines, indoleamines, and their metabolites in rat brain regions: prevention with 10-kW microwave irradiation.大鼠脑区儿茶酚胺、吲哚胺及其代谢产物的死后变化:10千瓦微波辐射的预防作用
J Neurochem. 1985 Sep;45(3):935-9. doi: 10.1111/j.1471-4159.1985.tb04083.x.
10
Determination of conjugated monoamine metabolites in brain tissue.脑组织中共轭单胺代谢物的测定。
J Neural Transm. 1976;39(4):281-90. doi: 10.1007/BF01266304.

引用本文的文献

1
Drugs repurposing in the experimental models of Alzheimer's disease.阿尔茨海默病实验模型中的药物再利用
Inflammopharmacology. 2025 Jan;33(1):195-214. doi: 10.1007/s10787-024-01608-7. Epub 2025 Jan 3.
2
Rodent Models of Alzheimer's Disease: Past Misconceptions and Future Prospects.阿尔茨海默病的啮齿动物模型:过去的误解和未来的前景。
Int J Mol Sci. 2024 Jun 5;25(11):6222. doi: 10.3390/ijms25116222.
3
Lower in vivo locus coeruleus integrity is associated with lower cortical thickness in older individuals with elevated Alzheimer's pathology: a cohort study.
体内蓝斑完整性较低与阿尔茨海默病病理水平升高的老年人皮质厚度较低有关:一项队列研究。
Alzheimers Res Ther. 2024 Jun 17;16(1):129. doi: 10.1186/s13195-024-01500-0.
4
Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer's disease and Parkinson's disease.蓝斑及其纤维束的微观结构完整性反映了阿尔茨海默病和帕金森病中的去甲肾上腺素能退行性变。
Transl Neurodegener. 2024 Feb 9;13(1):9. doi: 10.1186/s40035-024-00400-5.
5
Drug repurposing for neurodegenerative diseases using Zebrafish behavioral profiles.利用斑马鱼行为特征进行神经退行性疾病的药物重定位。
Biomed Pharmacother. 2024 Feb;171:116096. doi: 10.1016/j.biopha.2023.116096. Epub 2024 Jan 6.
6
Gut Microbial Metabolome and Dysbiosis in Neurodegenerative Diseases: Psychobiotics and Fecal Microbiota Transplantation as a Therapeutic Approach-A Comprehensive Narrative Review.肠道微生物代谢组学与神经退行性疾病中的菌群失调:益生菌和粪便微生物群移植作为一种治疗方法——全面的叙述性综述。
Int J Mol Sci. 2023 Aug 27;24(17):13294. doi: 10.3390/ijms241713294.
7
Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease.蓝斑核与神经退行性疾病中的去甲肾上腺素能药理学。
Handb Exp Pharmacol. 2024;285:555-616. doi: 10.1007/164_2023_677.
8
Poorer aging trajectories are associated with elevated serotonin synthesis capacity.较差的衰老轨迹与升高的血清素合成能力有关。
Mol Psychiatry. 2023 Oct;28(10):4390-4398. doi: 10.1038/s41380-023-02177-x. Epub 2023 Jul 17.
9
Cerebrospinal fluid and positron-emission tomography biomarkers for noradrenergic dysfunction in neurodegenerative diseases: a systematic review and meta-analysis.用于神经退行性疾病中去甲肾上腺素能功能障碍的脑脊液和正电子发射断层扫描生物标志物:一项系统评价和荟萃分析
Brain Commun. 2023 Mar 29;5(3):fcad085. doi: 10.1093/braincomms/fcad085. eCollection 2023.
10
The Contribution of the Locus Coeruleus-Noradrenaline System Degeneration during the Progression of Alzheimer's Disease.蓝斑-去甲肾上腺素系统退化在阿尔茨海默病进展过程中的作用
Biology (Basel). 2022 Dec 14;11(12):1822. doi: 10.3390/biology11121822.